| Deborah Hall, LPN | |
|
200 General St, Batesville, AR 72501-9407 | |
| (870) 793-3200 | |
| Not Available |
| Full Name | Deborah Hall |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 200 General St, Batesville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275128076 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | L055725 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Deborah Hall, LPN 200 General St, Batesville, AR 72501-9407 Ph: (870) 793-3200 | Deborah Hall, LPN 200 General St, Batesville, AR 72501-9407 Ph: (870) 793-3200 |
News Archive
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has been awarded a Qualifying Therapeutic Discovery Project grant (QTDP) from the U.S. Government. The grant, in the amount of $244,479, has been made to defer some of the Company's research expenditures related to the development of its novel and patented technology, CollaFix™, as a drug delivery device.
A new study of children in Ukraine has found that for the growing number of HIV-infected children, the quality of care and the relationship between children and their caregivers play an important role in their development.
HealthSparq, a leading provider of healthcare transparency solutions for health insurers, announced it has signed an agreement with MDLIVE to offer telehealth services through its transparency platform to health plans and employers across the nation.
Active Biotech and Ipsen today presented overall survival (OS) data from the tasquinimod Phase II study in chemotherapy-naïve metastatic castrate resistant prostate cancer (CRPC) at the scientific conference "2012 ASCO Annual Meeting" held in Chicago (USA).
Exelixis, Inc. today reported updated interim data from the cohort of patients with metastatic castration-resistant prostate cancer (CRPC) treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial.
› Verified 1 days ago
Brooke Finch, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2040 Fitzhugh St, Batesville, AR 72501 Phone: 870-793-3500 | |
Lauri Sumner, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2040 Fitzhugh St, Batesville, AR 72501 Phone: 870-793-3334 Fax: 870-793-3474 | |
Jennifer Robertson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2040 Fitzhugh St, Batesville, AR 72501 Phone: 870-793-3334 Fax: 870-793-3474 | |
Misty Morrow, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 200 General St, Batesville, AR 72501 Phone: 870-793-3200 | |
Michael Light, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2040 Fitzhugh St, Batesville, AR 72501 Phone: 870-793-3334 | |
Mr. Franz Gschwandegger, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2040 Fitzhugh St, Batesville, AR 72501 Phone: 870-793-3334 |